Verve Therapeutics, Inc.

Verve Therapeutics, Inc.verified

VERV

Price:

$4.85

Market Cap:

$410.62M

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and ...[Read more]

Industry

Biotechnology

IPO Date

2021-06-17

Stock Exchange

NASDAQ

Ticker

VERV

The Dividend Yield as of November 2024 (TTM) for Verve Therapeutics, Inc. (VERV) is 0%

According to Verve Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Verve Therapeutics, Inc. (VERV) Historical Dividend Yield (quarterly & annually)

How has VERV Dividend Yield performed in the past?

The mean historical Dividend Yield of Verve Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), VERV's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Verve Therapeutics, Inc. (VERV) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Verve Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%

Verve Therapeutics, Inc. (VERV) Average Dividend Yield

How has VERV Dividend Yield performed in the past?

The current Dividend Yield of Verve Therapeutics, Inc. (VERV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Verve Therapeutics, Inc. (VERV) Dividend Yield vs. Peers

How is VERV’s Dividend Yield compared to its peers?

Verve Therapeutics, Inc.’s Dividend Yield is less than Adaptive Biotechnologies Corporation (0%), less than Beam Therapeutics Inc. (0%), less than Caribou Biosciences, Inc. (0%), less than Sana Biotechnology, Inc. (0%), less than Intellia Therapeutics, Inc. (0%), less than Editas Medicine, Inc. (0%), less than CRISPR Therapeutics AG (0%), less than Prime Medicine, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%),

Build a custom stock screener for Verve Therapeutics, Inc. (VERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verve Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verve Therapeutics, Inc. (VERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verve Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Verve Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Verve Therapeutics, Inc. (VERV)?

What is the highest Dividend Yield for Verve Therapeutics, Inc. (VERV)?

What is the 3-year average Dividend Yield for Verve Therapeutics, Inc. (VERV)?

What is the 5-year average Dividend Yield for Verve Therapeutics, Inc. (VERV)?

How does the current Dividend Yield for Verve Therapeutics, Inc. (VERV) compare to its historical average?